Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
Department of Data Integration and Analysis, Statens Serum Institut, Copenhagen, Denmark.
Euro Surveill. 2024 Jun;29(24). doi: 10.2807/1560-7917.ES.2024.29.24.2400299.
We report an epidemic of parvovirus B19 infections in Denmark during the first quarter of 2024, with a peak incidence 3.5 times higher than during the most recent epidemic in 2017. In total, 20.1% (130/648) of laboratory-confirmed cases were pregnant. Severe adverse outcomes were observed among 12.3% (16/130) of pregnant people and included foetal anaemia, foetal hydrops and miscarriage. Parvovirus B19 infection is not systematically monitored, but a national laboratory-based surveillance system is currently being established in Denmark.
我们报告了丹麦在 2024 年第一季度爆发的细小病毒 B19 感染疫情,其峰值发病率比最近一次 2017 年的疫情高 3.5 倍。在总共 648 例实验室确诊病例中,20.1%(130/648)为孕妇。在 130 例孕妇中,有 12.3%(16/130)观察到严重不良后果,包括胎儿贫血、胎儿水肿和流产。细小病毒 B19 感染未被系统监测,但丹麦目前正在建立一个基于全国实验室的监测系统。